Ropivacaine hydrochloride liposome
盐酸罗哌卡因脂质体
Report date: 2022/11/24 15:37:50
Base Information
Drug NameRopivacaine hydrochloride liposome
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Luye Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesNanjing Luye Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A